Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Molecular Cancer Therapeutics|December 19, 2006
The endothelial cytoskeleton as a target of electroporation-based therapiesChryso Kanthou, Simona Kranjc, Gregor Sersa, et al.Trends in Endocrinology and Metabolism: TEM|May 13, 2020
Debunking the Myth of the Endogenous Antiangiogenic Vegfaxxxb TranscriptsHugues Dardente, William R English, Manoj K Valluru, et al.Journal of Medicinal Chemistry|October 4, 2016
Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4Andrew W Brown, Matthew Fisher, Gillian M Tozer, et al.Oncotarget|December 10, 2017
The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-<i>O</i>-phosphateJoanna Shepherd, Matthew Fisher, Abigail Welford, et al.Current Issues in Molecular Biology|April 26, 2024
The Vitamin K-Dependent Anticoagulant Factor, Protein S, Regulates Vascular PermeabilityAurélie Joussaume, Chryso Kanthou, Olivier E Pardo, et al.The American Journal of Pathology|October 7, 2004
The tubulin-binding agent combretastatin A-4-phosphate arrests endothelial cells in mitosis and induces mitotic cell deathChryso Kanthou, Olga Greco, Anna Stratford, et al.International Journal of Radiation Oncology, Biology, Physics|October 9, 2007
Radiation effects on the cytoskeleton of endothelial cells and endothelial monolayer permeabilityDorota Gabryś, Olga Greco, Gaurang Patel, et al.Plos One|May 9, 2012
Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary taleSheila Harris, Madeleine Craze, Jillian Newton, et al.Chemmedchem|October 4, 2018
Evaluation of Sydnone-Based Analogues of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer TherapyAndrew W Brown, Toby Holmes, Matthew Fisher, et al.Blood|October 16, 2012
The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent mannerSylvain Fraineau, Arnaud Monvoisin, Jonathan Clarhaut, et al.Pageof 3